Healthcare & Life Sciences

Orbicular Pharmaceutical Technologies

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

Orbicular Pharmaceutical Technologies develops and commercializes complex generic pharmaceutical products. They focus on difficult-to-manufacture injectables, ophthalmics, and drug-device combinations.

Explore Orbicular Pharmaceutical Technologies's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.